Results 221 to 230 of about 259,973 (292)

Targeting PD-L1-CMTM6 interactions in myeloid cells triggers PD-L1 degradation and enhances cytotoxic T-cell expansion. [PDF]

J Immunother Cancer
Hsu MA, Liu X, Barham W, Pavelko KD, Harrington SM, Lin C, Hirdler JB, Mao Z, Zhang W, Dellacecca ER, Ashton DS, Sun ND, Lancaster JN, Lucien F, Dong H.   +14 more
europepmc   +1 more source

Mitochondrial Enzymes Mimetic Ultrasmall Palladium Nanozymes Prevent Senescence and Neurodegeneration Through Metabolic Reprogramming

Advanced Science, EarlyView.
Simply constructed polyvinylpyrrolidone (PVP) modified palladium nanoparticles (PdP NPs) as cytochrome c oxidase (CcO) and superoxide dismutase (SOD) mimic are promising multifunctional nanoreactors to boost mitochondrial respiration chain function and refine homeostasis via regulation of mitochondrial dynamics and proteostasis sensor UPRmt, which ...
Wenshu Cong, Haiming Jing, Zinan Li, Wenjing Zhang, Nan Zhang, Yingqiu Xie, Shan Gao, Yuanyu Huang, Junyu Ning   +8 more
wiley   +1 more source

PD-L1-targeted PET imaging for non-invasive assessment of immunotherapy response in lung cancer. [PDF]

J Immunother Cancer
Chen Y, Liu X, Hu Y, Li A, Zeng B, Wang P, Tang G, Jiang B, Yuan H, Jiang L.   +9 more
europepmc   +1 more source

Copper Depletion Nanoparticles Potentiate Cancer Immunotherapy by Avoiding Innate and Adaptive Immune Resistance

Advanced Science, EarlyView.
A mitochondria‐targeted copper depletion nanoplatform (CYN‐CDA@Alb) was developed to selectively disrupt tumor mitochondria copper, which then reprogrammed the tumor immune microenvironment by depressing PD‐L1 and CD47 expression simultaneously. By doing this, CYN‐CDA@Alb reversed radiotherapy‐induced immune tolerance, showing the potential usage of ...
Zaigang Zhou, Ke Li, Xuelan Li, Lei Yi, Zhengxiang Wang, Huan Ding, Sheng Wu, Feiyu Liu, Yuan Li, Rui Cheng, Jianliang Shen   +10 more
wiley   +1 more source

Expression and role of PD-L1 and SOX10 in hepatocellular carcinoma. [PDF]

Transl Cancer Res
So BC, Park HJ, Kim KM, Park HS, Jang KY, Chung MJ, Moon WS, Yang JD, Ahn AR.   +8 more
europepmc   +1 more source

Bioorthogonal Fluorogenic Reporters for Noninvasive Imaging and Urinalysis of Immunotherapeutic Response in Renal Cell Carcinoma

Advanced Science, EarlyView.
This study reported renal‐clearable bio‐orthogonal near‐infrared fluorogenic probes (BGRs) that specifically imaging and urinalysis of granzyme B for dynamic evaluation of RCC immunotherapy. BGRs not only differentiate immunotherapeutic responses in orthotopic RCC mice, but also enable sensitive optical urinalysis of granzyme B in clinical specimens ...
Xingyue Yang, Baoshuai Liang, Liangmin Fu, Weiliang Deng, Yuyan Jiang, Weiping Xu, Jinwei Chen, Ya Zhou, Ke Wu, Jiaguo Huang   +9 more
wiley   +1 more source

Breast cancer microenvironment composition associated with high PD-L1 expression. [PDF]

BMC Cancer
Chekhun V, Lukianova Y, Mushii O, Zadvornyi T, Pavlova A, Burda T, Bazas V, Shepelenko I, Lukianova N.   +8 more
europepmc   +1 more source

High‐Throughput Screening and Interpretable Machine Learning for Rational Design of Bimetallic Catalysts for Methane Activation

Advanced Science, EarlyView.
ABSTRACT Methane's efficient catalytic removal is vital for sustainable development. Bimetallic catalysts, though promising for methane activation, pose a design challenge due to their complex compositional space. This work introduces an integrated framework that combines high‐throughput density functional theory (DFT) and interpretable machine ...
Mingzhang Pan, Tian Zhang, Jiawei Dong, Yubao Xie, Kaifeng Zhong, Wei Guan, Haiqiao Wei, Changcheng Fu, Yaqiong Su   +8 more
wiley   +1 more source

Prognostic significance of neuroendocrine differentiation and PD-L1 expression in treatment-naïve prostate cancer. [PDF]

BMC Urol
Tosun I, Sahin O, Bakkaloğlu İG, Şişik NM, Özçelik M.   +4 more
europepmc   +1 more source

PD-L1 Expression in Pancreatic Cancer [PDF]

Journal of the National Cancer Institute, 2017
openaire   +2 more sources